Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-09
1992-05-26
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3135
Patent
active
051168642
ABSTRACT:
Restenosis following vascular recanalization is prevented by administering a photoactivatable psoralen and, in conjunction with recanalization, delivering ultraviolet radiation to the region of said recanalization.
REFERENCES:
patent: 4169204 (1979-09-01), Hearst et al.
patent: 4269851 (1981-05-01), Kaufman
patent: 4269852 (1981-05-01), Kaufman
patent: 4294822 (1981-10-01), Kaufman
patent: 4321919 (1982-03-01), Edelson
patent: 4328239 (1982-05-01), Kaufman
patent: 4464354 (1984-08-01), Bisagni
patent: 4465691 (1984-08-01), Bisagni et al.
patent: 4512762 (1985-04-01), Spears
patent: 4577636 (1986-03-01), Spears
patent: 4753958 (1988-06-01), Weinstein
patent: 4771777 (1988-09-01), Horzewski et al.
patent: 4773899 (1988-09-01), Spears
patent: 4790315 (1988-12-01), Mueller et al.
patent: 4799479 (1989-01-01), Spears
patent: 4824436 (1989-04-01), Wolinsky
patent: 4878492 (1989-11-01), Sinofsky et al.
patent: 4892519 (1990-01-01), Songer et al.
patent: 4983625 (1991-01-01), Shroot et al.
Dartsch et al., Differential Effect of Photofrin II . . . , Arteriosclerosis 10:616 (1990).
Dartsch et al., Responses of Cultured Smooth Muscle Cells . . . , J. Am. Coll. Cardiol., 15:1545 (1990).
Benson, Treatment of Diffuse Transitional Cell Carcinoma . . . , J. Urol. 134:675, 678 (1985).
Dougherty et al., Photoradiation Therapy for the Treatment . . . , Cancer Res. 38:2628 (1978).
Lam et al., Detection of Early Lung Cancer Using Low Dose . . . , Chest 97:333 (1990).
Prout et al., Photodynamic Therapy with Hematoporphyrin . . . , New Eng. J. Med. 317:1251 (1987).
Razum et al., Skin Photosensitivity: Duration and Intensity . . . , Photochem. and Photobiol., 46:925 (1987).
Honigsmann, Photosensitizing Compounds: Their Chemistry . . . , (1989), p. 143 (Wiley).
Harber et al., Photosensitivity Diseases (1989), 69 (Decker).
Stern et al., Psoriasis, Roenigk, Ed. (1991) 604 (Dekker).
Laskin, Psoralens Potentiate Ultraviolet Light-Induced Inhibition . . . , Proc. Natl. Acad. Sci. 83:8211 (1986).
Gasparro, Psoralen DNA Photobiology (CRC Press, 1988).
Anderson et al., Psoralen Photochemistry of Cutaneous Disorders, Ann. Rev. Pharmicol. Toxicol. 20:235 (1980).
Fujii et al., Light-Scattering Properties of a Rough-Ended Optical Fiber, Optics and Laser Technol. 40 (Feb.) 1984.
Hathaway David R.
March Keith L.
Patton Brian L.
Wilensky Robert L.
Indiana University Foundation
Schenkman Leonard
LandOfFree
Method for preventing restenosis following reconfiguration of bo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing restenosis following reconfiguration of bo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing restenosis following reconfiguration of bo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-420219